Quadrant Capital Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.3M | Buy |
78,756
+1,322
| +2% | +$308K | 0.58% | 25 |
|
|
2025
Q4 | $16M | Buy |
77,434
+2,125
| +3% | +$420K | 0.48% | 25 |
|
|
2025
Q3 | $14M | Buy |
75,309
+9,966
| +15% | +$1.71M | 0.45% | 27 |
|
|
2025
Q2 | $9.98M | Buy |
65,343
+13,774
| +27% | +$2.12M | 0.36% | 36 |
|
|
2025
Q1 | $8.55M | Buy |
51,569
+29,274
| +131% | +$4.58M | 0.32% | 38 |
|
|
2024
Q4 | $3.22M | Sell |
22,295
-3,110
| -12% | -$482K | 0.22% | 52 |
|
|
2024
Q3 | $4.12M | Buy |
25,405
+190
| +0.8% | +$30.3K | 0.29% | 43 |
|
|
2024
Q2 | $3.69M | Sell |
25,215
-898
| -3% | -$134K | 0.27% | 47 |
|
|
2024
Q1 | $4.13M | Sell |
26,113
-1,849
| -7% | -$294K | 0.33% | 42 |
|
|
2023
Q4 | $4.38M | Sell |
27,962
-1,257
| -4% | -$193K | 0.38% | 39 |
|
|
2023
Q3 | $4.55M | Sell |
29,219
-426
| -1% | -$70.3K | 0.46% | 32 |
|
|
2023
Q2 | $4.91M | Buy |
29,645
+4,298
| +17% | +$694K | 0.49% | 30 |
|
|
2023
Q1 | $3.93M | Sell |
25,347
-5,110
| -17% | -$825K | 0.41% | 35 |
|
|
2022
Q4 | $5.38M | Buy |
30,457
+4,039
| +15% | +$697K | 0.61% | 25 |
|
|
2022
Q3 | $4.32M | Sell |
26,418
-303
| -1% | -$51.3K | 0.57% | 26 |
|
|
2022
Q2 | $4.74M | Buy |
26,721
+934
| +4% | +$166K | 0.64% | 27 |
|
|
2022
Q1 | $4.57M | Buy |
25,787
+1,211
| +5% | +$206K | 0.55% | 30 |
|
|
2021
Q4 | $4.2M | Buy |
24,576
+3,367
| +16% | +$551K | 0.5% | 37 |
|
|
2021
Q3 | $3.42M | Buy |
21,209
+1,531
| +8% | +$261K | 0.48% | 38 |
|
|
2021
Q2 | $3.24M | Buy |
19,678
+1,190
| +6% | +$197K | 0.47% | 36 |
|
|
2021
Q1 | $3.04M | Buy |
18,488
+1,912
| +12% | +$309K | 0.49% | 34 |
|
|
2020
Q4 | $2.61M | Sell |
16,576
-83
| -0.5% | -$12.2K | 0.48% | 32 |
|
|
2020
Q3 | $2.48M | Sell |
16,659
-235
| -1% | -$34.8K | 0.54% | 30 |
|
|
2020
Q2 | $2.38M | Sell |
16,894
-7,979
| -32% | -$1.16M | 0.53% | 32 |
|
|
2020
Q1 | $3.26M | Buy |
24,873
+1,741
| +8% | +$247K | 0.55% | 30 |
|
|
2019
Q4 | $3.34M | Buy |
23,132
+3,814
| +20% | +$517K | 0.4% | 37 |
|
|
2019
Q3 | $2.48M | Sell |
19,318
-2,418
| -11% | -$319K | 0.38% | 42 |
|
|
2019
Q2 | $3M | Buy |
21,736
+2,740
| +14% | +$379K | 0.48% | 34 |
|
|
2019
Q1 | $2.63M | Buy |
18,996
+2,445
| +15% | +$328K | 0.46% | 36 |
|
|
2018
Q4 | $2.12M | Buy |
16,551
+220
| +1% | +$30.7K | 0.56% | 29 |
|
|
2018
Q3 | $2.24M | Sell |
16,331
-546
| -3% | -$72.6K | 0.64% | 27 |
|
|
2018
Q2 | $2.02M | Buy |
16,877
+323
| +2% | +$40.3K | 0.71% | 24 |
|
|
2018
Q1 | $2.1M | Buy |
16,554
+3,176
| +24% | +$429K | 0.76% | 24 |
|
|
2017
Q4 | $1.85M | Buy |
13,378
+473
| +4% | +$65.9K | 0.74% | 24 |
|
|
2017
Q3 | $1.66M | Sell |
12,905
-11
| -0.1% | -$1.46K | 0.68% | 25 |
|
|
2017
Q2 | $1.63M | Sell |
12,916
-324
| -2% | -$41.3K | 0.72% | 23 |
|
|
2017
Q1 | $1.63M | Buy |
13,240
+1,679
| +15% | +$201K | 0.72% | 23 |
|
|
2016
Q4 | $1.32M | Sell |
11,561
-284
| -2% | -$32.8K | 0.66% | 29 |
|
|
2016
Q3 | $1.38M | Buy |
11,845
+1,117
| +10% | +$136K | 0.9% | 16 |
|
|
2016
Q2 | $1.29M | Sell |
10,728
-929
| -8% | -$106K | 0.89% | 18 |
|
|
2016
Q1 | $1.25M | Buy |
11,657
+923
| +9% | +$95.6K | 0.81% | 22 |
|
|
2015
Q4 | $1.09M | Sell |
10,734
-1,588
| -13% | -$160K | 0.76% | 21 |
|
|
2015
Q3 | $1.14M | Buy |
12,322
+749
| +6% | +$72.5K | 0.79% | 20 |
|
|
2015
Q2 | $1.12M | Buy |
+11,573
| New | +$1.16M | 0.71% | 23 |
|
Other funds holding JNJ
VCM
VPM
Quadrant Capital Group's JNJ Position: Q1 2026 in Review
Quadrant Capital Group increased its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2026, buying an estimated $308K and bringing the position to 78,756 shares worth $19.3M. The position accounts for 0.58% of the portfolio, ranked #25.
Quadrant Capital Group first reported a position in JNJ in Q2 2015 and has held it in 44 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Quadrant Capital Group held 78,756 shares of Johnson & Johnson worth $19.3M as of Q1 2026.
- Quadrant Capital Group bought 1,322 Johnson & Johnson shares in Q1 2026, an estimated $308K.
- Johnson & Johnson made up 0.58% of Quadrant Capital Group's portfolio in Q1 2026, its #25 holding.
- Quadrant Capital Group first reported a position in Johnson & Johnson in Q2 2015 and has held it in 44 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.